"A Multicenter Placebo-Controlled Double Blind Study to Evaluate the Efficacy and Safety of Sandostatin ( SMS 201-995 ) in Patients With Acquired Immunodeficiency Related Diarrhea Who Were Either Responders or Non-Responders in a Prior Placebo-Controlled Double-Blind Sandostatin Study."

Mount Sinai Med Ctr, New York

Buckley Braffman Stern Med Associates, Philadelphia

Infectious Disease Physicians Inc, Annandale

Emory Univ School of Medicine, Atlanta

Med Service, Miami

Henry Ford Hosp, Detroit

Univ of Wisconsin School of Medicine, Madison

Rush Presbyterian - Saint Luke's Med Ctr, Chicago

Univ of Missouri at Kansas City School of Medicine, Kansas City

Baylor College of Medicine, Houston

Univ TX Galveston Med Branch, Galveston

USC School of Medicine, Los Angeles

UCSD Med Ctr, San Diego

UCSF - San Francisco Gen Hosp, San Francisco

Kaiser Permanente Med Ctr, San Francisco

San Mateo County Gen Hosp, San Mateo

Portland Veterans Adm Med Ctr / Rsch & Education Grp, Portland

SUNY Stony Brook / Health Sciences Ctr, Stony Brook

Maine Med Ctr Med Clinics, Portland

Douglas Plesko, Boston

Boston City Hosp, Boston

Miriam Hosp / Family Healthcare Ctr at SSTAR, Providence